CRVL — CorVel Corporation

CorVel Corporation (CRVL) Q3 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Revenue: For the nine months ending December 31, 2025, revenue was $710 million, up 7% from $664 million in the prior year. The December 2025 quarter revenue was $236 million, a 3% increase from $228 million in December 2024.
• Earnings Per Share (EPS): Fiscal year-to-date EPS was $1.53, a 16% increase from $1.32 in the previous year. EPS for the December quarter was $0.47, up 2% from $0.46 in the same quarter last year.
• Net Income: The company reported a net income of $24.1 million for December 2025, slightly up from $23.8 million in December 2024.
• Cash Flow and Balance Sheet: The quarter-ending cash balance was $230 million, with fiscal year-to-date free cash flow at $90 million. CorVel repurchased 185,559 shares for $13.4 million during the quarter, totaling $868 million in share repurchases since inception.

2. Strategic Updates and Business Highlights

• AI Integration: CorVel is leveraging AI to enhance operational efficiency, automate lower-value activities, and improve client outcomes. This includes technology-driven improvements in claims management and case management.
• Market Trends: The company noted trends in the workers' compensation market, including a decrease in work-related injuries but an increase in injury severity and medical costs, suggesting growth opportunities for managed services.
• Product Innovation: Continued focus on product development in network solutions and patient management services, with a technology-centric acquisition completed in June 2025 to enhance health payment integrity services.

3. Forward Guidance and Outlook

• Growth Potential: CorVel remains optimistic about future growth, citing a 100% net revenue retention rate and a 44% close rate on new business opportunities. The company anticipates that its investments in technology and AI will yield long-term benefits despite potential pricing pressures.
• Market Position: The company is well-positioned to capitalize on evolving market dynamics, particularly in healthcare payment integrity, as regulatory scrutiny increases and financial pressures mount on payers.

4. Bad News, Challenges, or Points of Concern

• Deceleration in Revenue Growth: The company acknowledged a deceleration in year-over-year revenue growth, which has raised concerns among analysts. Management emphasized that this is part of a broader historical trend rather than a fundamental shift.
• Increased Effective Tax Rate: An increase in the effective tax rate tempered earnings results, which may impact future profitability.
• Competitive Pressures: CorVel faces challenges from competitors who may have significant debt obligations, potentially affecting their financial agility and ability to innovate.

5. Notable Q&A Insights

• Revenue Growth Discussion: Management addressed concerns about the deceleration in revenue growth, attributing it to short-term operational factors and reaffirming confidence in the company's long-term trajectory.
• Segment Reporting: In response to inquiries about segment performance, management clarified that CorVel operates within a single segment encompassing patient management and network solutions, and does not report on individual product lines.

Overall, while CorVel Corporation reported solid financial results and strategic advancements, it faces challenges related to revenue growth deceleration and increased tax rates, which could impact future performance. The company remains focused on leveraging technology and AI to enhance its market position and operational efficiency.